失眠认知行为治疗的卫生经济学研究现状

张晶; 苑成梅

doi:10.12182/20230360102

失眠认知行为治疗的卫生经济学研究现状

doi: 10.12182/20230360102

张晶,
苑成梅^,

上海交通大学医学院附属精神卫生中心（上海 200000）

基金项目: 上海市申康发展中心重大临床研究项目-青年项目（No. SHDC2020CR4074）、上海市申康发展中心“适宜技术联合开发推广应用”项目（No. SHDC12016205）、上海市科委科技创新行动计划（No. 20Y11906600）、上海市精神心理疾病临床医学研究中心项目（No. 19MC1911100）和上海市卫健委上海市中医药事业发展三年行动计划（2018年–2020年）治未病服务重点推广项目〔No. ZY(2018-2020)-ZWB-1001-FWB-07〕资助

详细信息

通讯作者:
E-mail：yuanchengmei@yeah.net

计量
- 文章访问数: 1262
- HTML全文浏览量: 40
- PDF下载量: 46
- 被引次数: 0
出版历程
- 收稿日期: 2022-10-17
- 修回日期: 2023-01-28
- 网络出版日期: 2023-03-22
- 刊出日期: 2023-03-20

Status of Health Economics Research on Cognitive Behavioral Therapy for Insomnia

ZHANG Jing,
YUAN Cheng-mei^,

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China

More Information

Corresponding author: E-mail: yuanchengmei@yeah.net

摘要

摘要: 失眠的认知行为治疗（cognitive behavioral therapy for insomnia, CBT-I）是治疗失眠障碍的一线治疗方法。本文回顾了目前主要的CBT-I应用形式及相应的卫生经济学研究，并与药物治疗进行比较，发现目前多数证据表明CBT-I效果持久，可以降低未来医疗花费，具有长期的经济优势。目前我国没有关于CBT-I经济效益的相关研究报道，本综述可为我国未来开展相关研究提供参考，也为临床医生与失眠患者在未来选择CBT-I作为失眠的治疗方案提供经济学视角的参考。
- 失眠障碍 /
- 失眠认知行为治疗 /
- 卫生经济学
Abstract: Cognitive behavioral therapy for insomnia (CBT-I) is a first-line treatment for insomnia disorder. Herein, we reviewed the currently prevailing forms of application of CBT-I and the corresponding studies on their health economics, comparing them with medication treatment. At present, most of the findings suggest that CBT-I has long-lasting effects and can help reduce future medical costs, thus showing long-term economic advantages. At present, there are no relevant research reports on the economic benefits of CBT-I in China. This review could provide reference for relevant studies to be conducted in the future in China. In addition, it provides reference from an economic perspective for clinicians and patients and facilitates their decision-making concerning using CBT-I as a treatment option for insomnia in the future.
- Insomnia disorder /
- Cognitive behavioral therapy for insomnia /
- Health economics

HTML全文

参考文献(29)

[1]	OZMINKOWSKI R J, WANG S, WALSH J K. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep,2007,30(3): 263–273. doi: 10.1093/sleep/30.3.263
[2]	REYNOLDS S A, EBBEN M R. The cost of insomnia and the benefit of increased access to evidence-based treatment: cognitive behavioral therapy for insomnia. Sleep Med Clin,2017,12(1): 39–46. doi: 10.1016/j.jsmc.2016.10.011
[3]	DALEY M, MORIN C M, LEBLANC M, et al. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep,2009,32(1): 55–64. doi: 10.5665/sleep/32.1.55
[4]	WICKWIRE E M, SHAYA F T, SCHARF S M. Health economics of insomnia treatments: The return on investment for a good night's sleep. Sleep Med Rev,2016,30: 72–82. doi: 10.1016/j.smrv.2015.11.004
[5]	TRAUER J M, QIAN M Y, DOYLE J S, et al. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med,2015,163(3): 191–204. doi: 10.7326/M14-2841
[6]	WANG Y Y, YANG Y, RAO W W, et al. Cognitive behavioural therapy monotherapy for insomnia: a meta-analysis of randomized controlled trials. Asian J Psychiatr,2020,49: 101828. doi: 10.1016/j.ajp.2019.10.008
[7]	SEYFFERT M, LAGISETTY P, LANDGRAF J, et al. Internet-delivered cognitive behavioral therapy to treat insomnia: a systematic review and meta-analysis. PLoS One,2016,11(2): e0149139. doi: 10.1371/journal.pone.0149139
[8]	KOFFEL E A, KOFFEL J B, GEHRMAN P R. A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Med Rev,2015,19: 6–16. doi: 10.1016/j.smrv.2014.05.001
[9]	LÉGER D, BAYON V. Societal costs of insomnia. Sleep Med Rev,2010,14(6): 379–389. doi: 10.1016/j.smrv.2010.01.003
[10]	KYLE S D, MILLER C B, ROGERS Z, et al. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep,2014,37(2): 229–237. doi: 10.5665/sleep.3386
[11]	LÉGER D, MORIN C M, UCHIYAMA M, et al. Chronic insomnia, quality-of- life, and utility scores: comparison with good sleepers in a cross-sectional international survey. Sleep Med,2012,13(1): 43–51. doi: 10.1016/j.sleep.2011.03.020
[12]	MORGAN K, DIXON S, MATHERS N, et al. Psychological treatment for insomnia in the regulation of long-term drug use. Health Technol Assess,2004,8(8): iii–iv,1-68. doi: 10.3310/hta8080
[13]	ZWEERDE T, BISDOUNIS L, KYLE S D, et al. Cognitive behavioral therapy for insomnia: a meta-analysis of long-term effects in controlled studies. Sleep Med Rev,2019,48: 101208. doi: 10.1016/j.smrv.2019.08.002
[14]	EDINGER J D, ARNEDT J T, BERTISCH S M, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis and GRADE assessment. J Clin Sleep Med,2021,17(2): 263–298. doi: 10.5664/JCSM.8988
[15]	MCCRAE C S, BRAMOWETH A D, WILLIAMS J, et al. Impact of brief cognitive behavioral treatment for insomnia on health care utilization and costs. J Clin Sleep Med,2014,10(2): 127–135. doi: 10.5664/jcsm.3436
[16]	WATANABE N, FURUKAWA T A, SHIMODERA S, et al. Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: analysis of a randomized controlled trial. Psychiatry Clin Neurosci,2015,69(6): 335–343. doi: 10.1111/pcn.12237
[17]	徐莲莲, 薛闯, 胡霖霖, 等. 原发性失眠患者团体认知行为治疗的随机对照试验. 中国心理卫生杂志,2020,34(12): 971–976. doi: 10.3969/j.issn.1000-6729.2020.12.001
[18]	YAMADERA W, SATO M, HARADA D, et al. Comparisons of short-term efficacy between individual and group cognitive behavioral therapy for primary insomnia. Sleep Biol Rhythms,2013,11(3): 176–184. doi: 10.1111/sbr.12019
[19]	BONIN E M, BEECHAM J, SWIFT N, et al. Psycho-educational CBT-Insomnia workshops in the community. A cost-effectiveness analysis alongside a randomised controlled trial. Behav Res Ther,2014,55: 40–47. doi: 10.1016/j.brat.2014.01.005
[20]	FIONA Y H, CHRISTIAN S C, WING Y L, et al. The effect of self-help cognitive behavioral therapy for insomnia on depressive symptoms: an updated meta-analysis of randomized controlled trials. J Affect Disord,2020,265: 287–304. doi: 10.1016/j.jad.2020.01.062
[21]	SALOMONSSON S, SANTOFT F, LINDSATER E, et al. Stepped care in primary care-guided self-help and face-to-face cognitive behavioural therapy for common mental disorders: a randomized controlled trial. Psychol Med,2018,48(10): 1644–1654. doi: 10.1017/S0033291717003129
[22]	BUNTROCK C, LEHR D, SMIT F, et al. Guided internet-based cognitive behavioral therapy for insomnia: health-economic evaluation from the societal and public health care perspective alongside a randomized controlled trial. J Med Internet Res,2021,23(5): e25609. doi: 10.2196/25609
[23]	HANNE T, DANIEL E D, DIRK L, et al. Internet-based cognitive behavioral therapy for insomnia: a health economic evaluation. Sleep,2016,39(10): 1769–1778. doi: 10.5665/sleep.6152
[24]	MICHAEL D, ESPIE C A, CARL J R, et al. Cost-effectiveness of digital cognitive behavioral therapy (Sleepio) for insomnia: a Markov simulation model in the United States. Sleep,2021,44(4): zsaa223. doi: 10.1093/sleep/zsaa223
[25]	MURPHY Y, WILSON E, GOLDNER E M, et al. Benzodiazepine use, misuse, and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995. Clin Drug Investing,2016,36(7): 519–530. doi: 10.1007/s40261-016-0397-8
[26]	阙建宇, 陈斯婧, 邓佳慧, 等. 失眠认知行为治疗在精神障碍中的应用. 中华行为医学与脑科学杂志,2022,31(1): 82–88. doi: 10.3760/cma.j.cn371468-20210901-00505
[27]	FREEMAN D, WAITE F, STARTUP H, et al. Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial. Lancet Psychiatry,2015,2(11): 975–983. doi: 10.1016/S2215-0366(15)00314-4
[28]	APOSTOLOS T, FELICITY W, DANIEL F, et al. Cost-effectiveness of cognitive-behavioural therapy for sleep disorder added to usual care in patients with schizophrenia: the BEST study. Bjpsych Open,2018,4(3): 126–135. doi: 10.1192/bjo.2018.2
[29]	TANNENBAUM C, DIABY V, SINGH D, et al. Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US medicare perspective. Drugs Aging,2015,32(4): 305–314. doi: 10.1007/s40266-015-0251-3